Clinical trials on the efficacy and safety of enhanced antihypertensive therapy in the Immediately post onset of non-traumatic intracerebral haemorrhage.

Clinical trials on the efficacy and safety of enhanced antihypertensive therapy in the Immediately post onset of non-traumatic intracerebral haemorrhage. - Clinical trials on the efficacy and safety of enhanced antihypertensive therapy in the Immediately post onset of non-traumatic intracerebral haemorrhage.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000055204

Enrollment

Registered

2024-08-09

Start date

2023-09-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Traumatic Intracerebral Hemorrhage

Interventions

In the diagnosis of non-traumatic intracerebral hemorrhage, a contrast-enhanced CT scan is performed to investigate the cause of the hemorrhage. If surgery is indicated depending on the location and e

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with non-traumatic intracerebral hemorrhage and positive Leakage sign on contrast-enhanced CT scan are eligible. Patients who are between 20 and 90 years of age at the time of consent. Patients who have obtained written consent from the patient or a surrogate. Patients whose respiratory and circulatory status is stable from the time of admission to the contrast CT scan.

Exclusion criteria

Exclusion criteria: Pregnant women or those who may be pregnant Patients whose respiratory and circulatory status has not stabilized between the time of admission and the contrast-enhanced CT scan. Those who have been resuscitated after cardiopulmonary arrest Those who are judged to be unsuitable as research subjects by the principal investigator and research coordinators.

Design outcomes

Primary

Measure	Time frame
Hematoma enlargement or not	—

Secondary

Measure	Time frame
Presence of renal dysfunction, functional prognosis	—

Countries

Japan

Contacts

Public ContactSosho Kajiwara

Kurume University School of Medicine Department of Neurosurgery

kajiwara_soushou@med.kurume-u.ac.jp0942-31-7570

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026